India's industrial output for April reached 4.9% under a revised Index of Industrial Production (IIP) series with an updated base year of 2...

India is updating its Index of Industrial Production. The new series will use 2022-23 as the base year, replacing the old 2011-12 base. Thi...

A rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...

If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Mankind Pharma announced a significant 30 percent profit increase for the fourth quarter. This growth was fueled by strong demand for chron...

Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...

The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...

A viral video from Sunbeam School, Hardoi shows principal Mamta Mishra shouting at parents during a fee dispute, triggering backlash on X. ...

What is evident in the last few trading sessions is how the street is treating Q4 earnings numbers. If a company delivers in terms of numbe...

The Central Drugs Standard Control Organization (CDSCO) has granted permission to the Christian Medical College, Vellore to conduct phase-I...

"We have permission from Data and Safety Monitoring Board (DSMB) to unblind our analysis. On Monday, we approached the drug regulator to gi...

As part of the study, a total of 330 healthy volunteers who were not vaccinated and had no history of COVID infection were selected and scr...

The findings are particularly important when considering administering third booster dose aiming to elicit robust antibody response and hel...

"One could give an additional dose of the same vaccine but the results aren't as good as when the jabs are mixed," a senior government offi...

Some countries like Spain and Germany are already using mixed doses.

Combining vaccines, say with a first dose of a viral vector vaccine like Oxford-AstraZeneca’s Covishield and a second dose of an mRNA jab l...

People who got a first dose of AstraZeneca Plc’s shot followed by Pfizer Inc.’s vaccine four weeks later reported more short-lived side eff...